FTC Balks At Discovery Extension In AndroGel Antitrust Suit
The Federal Trade Commission objected Wednesday to a group of pharmaceutical companies' request for two more months of expert discovery in an antitrust case alleging they conspired to keep generic competitors...To view the full article, register now.
Already a subscriber? Click here to view full article